advanced PD | Malaty et al. | Our calculations of accuracy measures | |||||||
---|---|---|---|---|---|---|---|---|---|
5-2-1 screening criteria | yes | no | ∑ | CCR (A+D)/(A+B+C+D) | SENSA/(A+C) | SPECD/(C+D) | PPVA/(A+B) | ||
pos | 552A | 994B | 1546 | 88.1% | 75.7% | 78.6% | 75.2% | 35.7% | |
neg | 150C | 3018D | 3168 | ||||||
∑ | 702 | 4012 | 4714 | ||||||
≥ 2 h off-time/day | yes | no | ∑ | 88.4% | 80.5% | 70.4% | 82.2% | 40.9% | |
pos | 494A | 713B | 1207 | ||||||
neg | 208C | 3299D | 3507 | ||||||
∑ | 702 | 4012 | 4714 | ||||||
≥ 1 h troublesome dyskinesia/day | yes | no | ∑ | 87.1% | 86.0% | 15.8% | 98.3% | 62.0% | |
pos | 111A | 68B | 179 | ||||||
neg | 591C | 3944D | 4535 | ||||||
∑ | 702 | 4012 | 4714 | ||||||
≥ 5 doses of oral levodopa/day | yes | no | ∑ | 87.1% | 80.4% | 41.2% | 87.3% | 36.1% | |
pos | 289A | 511B | 800 | ||||||
neg | 413C | 3501D | 3914 | ||||||
∑ | 702 | 4012 | 4714 |